MediSel
ActiveSummary
MediSel has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €81,250 and a net result of €25,016. Equity is growing by ~50.4% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 0.6% (low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 28 days late
2025
31-12
Financial
Liquidity triplescurrent ratio 7.68
Current ratio from 2.98 to 7.68; short-term debt falls from €24,768 to €12,163.
30-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2023net €31,652 ▲37.1%
Operating result €44,129, net result €31,652, both a record.
31-12
Financial
Liquidity doublescurrent ratio 2.98
Current ratio from 1.40 to 2.98; short-term debt falls from €24,822 to €24,768.
31-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.